BioCentury
ARTICLE | Clinical News

DiaMedica preclinical data

August 9, 2010 7:00 AM UTC

In a delayed hypersensitivity model, a single dose of DM-99 significantly reduced skin inflammation by 67% vs. control (p<0.05). Furthermore, skin inflammation following a single dose of the undisclos...